nDatalyze Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- James Morris Durward
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 707 – 7th Avenue SW Calgary AB Canada T2P 3H6
- IPO Date
- Jul 15, 2021
- Website
- ndatalyze.com
- Similar Companies
- Business
- nDatalyze Corp. (CSE:NDAT, OTCQB:NDATF), founded in 2018 and headquartered in Calgary, Alberta, Canada, develops technology-based health solutions leveraging machine learning and specialized databases. The company operates three primary divisions offering distinct products and services: the YMI division provides a data-driven mobile health application that uses supervised artificial intelligence, biometric records, electroencephalogram data, genetic expressions, and life experiences to predict predispositions for mental health conditions including anxiety, depression, post-traumatic stress disorder, obsessive-compulsive disorder, alcoholism, and personality disorders; the MLdelic division delivers a database platform to forecast benefits from entheogenic compounds in mental health treatments; and the Medxtractor division manufactures patented small-scale carbon dioxide-based bio-extractors for essential oils and botanical compounds, with installations worldwide. nDatalyze targets consumer and healthcare markets in Canada and the United States through electronic medical record platforms and direct-to-consumer access. In recent developments, the company completed due diligence on a proposed reverse takeover transaction in January 2025, announced a letter of intent for a reverse merger in December 2024, launched AI-based depression assessment availability via major Canadian EMR platforms in December 2024, reversed its April 2024 acquisition of Mindbalanced Inc. in November 2024 following positive clinical study results in October 2024, closed a US$150,000 private placement in April 2024 to fund the initial Mindbalanced operations, and reactivated its OTCQB listing in the United States in August 2024.
nDatalyze Corp. Enters A Binding Business Combination Agreement With Prism Diversified Ltd.
nDatalyze Corp. Announces Appointment of Commercial Sales Director for the Epitome Hockey Platform.
nDatalyze Corp. Announces Adoption of Semi-Annual Financial Reporting Trial, provides a progress report on the potential RTO, and updates the Epitome sports performance assessment project
nDatalyze Corp. Updates The Proposed RTO With An Alberta-Based Mining Company
nDatalyze Corp. enters a Non-Binding Memorandum of Understanding with an Alberta-based mining company.
CSE Bulletin: Resumption - nDatalyze Corp. (NDAT)
nDatalyze Corp. announces termination of the proposed RTO with a Vancouver-based private company ("FoodCo")
nDatalyze Corp. Updates the RTO Progress
nDatalyze Corp. updates the "Epitome" Predictive Sports Performance Analytics Project and the RTO progress.
nDatalyze Corp. updates the "Epitome" Predictive Sports Performance Analytics Project and the RTO progress
nDatalyze Corp. announces initiation of "Epitome", a Predictive Sports Performance Project leveraging AI to address a Multi-Billion Dollar Sports Analytics Market